ONGENO
Polish medtech startup ONGENO has a therapy developed by Dr. Wojciech Orlowski, M.D., which has been proven in the first phase of the experiment to lead to improved sclerosis patient health, reduced disability, and lack of disease progression in the long term.
ONGENO has raised €3.5M across 1 funding round, most recently a round in Jan 2025. Based in Warsaw, Poland; active in Healthtech. Data as of 28 Oct 2026.
Warsaw, Polandwww.ongeno.com ↗
Total raised
€3.5M
€3,500,000
Funding rounds
1
Investors
0
distinct backers
Active since
2025-01
latest 2025-01
Funding by year
EUR raised per yearONGENO — funding by year — interactive chart.
Data table
| ONGENO — funding by year | |
|---|---|
| 2025 | €3.5M |
Signals
Medium confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-01-21 | Other | €3.5M | — | View deal → |
Related news
Similar companies
same sector or country- InPost€2.8BPoland · Transportation
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Allegro€2.0BPoland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData